By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    UV damage to eyes
    Warning Signs of Long-Term UV Damage to Your Eyes
    December 9, 2021
    degree for healthcare job
    The Ultimate Healthcare Recruiting and Staffing Guidebook
    March 21, 2022
    medicare part d benefits
    Everything that You Need to Know About Medicare Part D
    August 15, 2022
    Latest News
    3 Ways To Deal With Health Issues In Cities With High Pollution
    March 22, 2023
    What Tools Should Your Caregiver Have?
    March 22, 2023
    How to Combat Home Sickness After Moving Abroad
    March 19, 2023
    4 Ways to Recover from a Broken Hip
    March 14, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Readmission Rates getting you down? BHM can help. Call 1-888-831-1171 for a free consultation.
    The Top 5 Mistakes Hospitals with High Readmission Rates Are Making
    June 27, 2014
    Fragmentation: The Enemy of Patient Outcomes
    May 1, 2015
    Like I said: United’s ACA exchange departure is no big deal
    January 29, 2016
    Latest News
    What Are Bioidentical Hormones Made With?
    March 23, 2023
    Cover Medical Costs of Child Dog Bites with Legal Specialists
    March 23, 2023
    3 Ways to Improve the U.S. Healthcare System By 2030
    March 14, 2023
    6 Steps To Ensure Speed And Efficiency Of Clinical Studies
    March 14, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Orphan Lit: Patient Perspective on the Risk Benefit Trade-Off
Share
Sign In
Notification Show More
Latest News
The Best Natural Sleep Remedies & Aids
The Best Natural Sleep Remedies & Aids
Wellness
Bioidentical Hormones
What Are Bioidentical Hormones Made With?
Medical Education
chemical peels for skin disorders
Chemical Peels Can Do Wonders for Treating Skin Disorders
Skin
health benefits of lip enhancements
Cleveland Clinic Cites Health Benefits of Lip Enhancements
lifestyle
child dog bite lawyer
Cover Medical Costs of Child Dog Bites with Legal Specialists
News
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Diagnostics > Orphan Lit: Patient Perspective on the Risk Benefit Trade-Off
Diagnostics

Orphan Lit: Patient Perspective on the Risk Benefit Trade-Off

dorothywetzel
Last updated: 2013/04/25 at 6:07 AM
dorothywetzel
Share
6 Min Read
orphan drug
SHARE

Continuing extrovertic’s interest in Orphan Drug Literature, I read an inspiring book, “Reaching Beyond the Clouds,” by Cindy L. Abbott. The book takes readers from Cindy’s diagnosis with the rare disease Wegener’s Granulomatosis through her successful ascent of Mount Everest.

Continuing extrovertic’s interest in Orphan Drug Literature, I read an inspiring book, “Reaching Beyond the Clouds,” by Cindy L. Abbott. The book takes readers from Cindy’s diagnosis with the rare disease Wegener’s Granulomatosis through her successful ascent of Mount Everest. I thank the OrphanDruganaut post for introducing me to this riveting book. As rare as Wegener’s is (less than 3,000 people are diagnosed each year in the US), the number of American women who have summited Mt. Everest (45), is even smaller.1 Cindy managed to accomplish something even more rare than her disease.

orphan drug

In addition to being an inspirational read, the book provides perspective on how patients with rare and orphan diseases view risk benefit choices. As a consequence of her disease, Cindy had lost much of the sight in her left eye before she even embarked on her mountaineering path. With so little known about the disease progression of Wegener’s, it was a major risk for Cindy to scale any mountain, much less Everest. Would the high altitude conditions result in more vision loss? Would the relentless freezing conditions make her even more susceptible to the frostbite?

More Read

Medical device classification and development strategies

Medical device classification and development strategies

8 Proven Tips on Finding Difficult Veins
How Do I Prove Delayed Diagnosis or Misdiagnosis?
Best Hospital to Treat Prostate Cancer
New Medical Laboratories Are the Key to Diagnostics Research

Weighing the well-known risks and rewards of summiting Everest, factoring in the additional unknowable risk that her disease posed, Cindy decided to go for it. As she says, “I wasn’t about to allow the disease to become the writer and director of The Life and Times of Cindy Abbott. I had a mountain to climb, and Everest was what I focused on.”

Cindy’s risk benefit trade-off is just an extreme version of the types of decisions parents of patients with rare and orphan diseases make on a daily basis. Do I let my daughter with cystic fibrosis swim in a murky lake with her friends where she could be exposed to potentially exacerbation causing mold? Or do I keep her home and make her feel even less like a normal teenager?

So it stands to reason that these patients and their family members are especially well equipped to consider the trade-off of a new therapy requires; e.g. is the benefit of the drug worth the risk of a potentially dangerous or life-threatening side effect?

The FDA recognizes rare and orphan disease patients may have a different perspective about risk benefit trade-offs than patients suffering from more common and less life-threatening diseases. In fact, the FDA has an entire initiative dedicated to infusing the voice of the patient into the approval process for drugs that treat rare and orphan diseases. The FDA initiative is called, “Patient-Focused Drug Development.”

As outlined in the FDA website, the rational for this effort is that “drug development and FDA’s review process could benefit from a more systematic and expansive approach to obtaining the patient perspective on disease severity and current available options in a therapeutic area.” A key component of this initiative is a series of patient meetings in 20 different therapeutic classes over the course of 2013-14.

The implication for marketers is that if the FDA is stepping up their efforts to get the voice of the patient into their approval process, shouldn’t industry be doing the same? It is a fairly common practice to hold patient advisory boards 1-2 times a year. The larger challenge is incorporating a continual drumbeat of the patient voice into your drug and communications development. Here are two suggestions:

  1. Meet regularly with individual patients. Make it a practice to bring a patient into your office once a month or at the very least, once a quarter. Set up a series of small meetings with your colleagues and agency partners. Have the patient tell his or her story. One of my clients did this regularly, every time she met a particularly articulate patient. It gave the entire organization an incredible empathy for patients and made it easier to secure funding for patient programs.
  2. Analyze online patient conversations. With the right tools, the patient journey can be mapped out using online patient conversations. Patient needs and emotional states can be pinpointed for each stage of the journey. And the results can be obtained more quickly and economically than traditional research.

Of course, there are risks involved anytime the pharmaceutical industry interacts with a patient. Are you inadvertently giving away confidential market-moving information? Are you raising false hopes?  But the benefit of delivering a drug or piece of education that truly meets the needs of the patient surely outweighs the risk.

1. According to “Reaching Beyond the Clouds” as of 2010 45 American females have summited Mt. Everest

TAGGED: orphan drug, pharma

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
dorothywetzel April 25, 2013
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article Image Serendipity and Personalization and Connected Health
Next Article physician health Have Physicians Lost Their MoJo?

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

The Best Natural Sleep Remedies & Aids
The Best Natural Sleep Remedies & Aids
Wellness March 23, 2023
Bioidentical Hormones
What Are Bioidentical Hormones Made With?
Medical Education March 23, 2023
chemical peels for skin disorders
Chemical Peels Can Do Wonders for Treating Skin Disorders
Skin March 23, 2023
health benefits of lip enhancements
Cleveland Clinic Cites Health Benefits of Lip Enhancements
lifestyle March 23, 2023

You Might also Like

Diagnostic Tools for doctors
Diagnostics

7 Essential Diagnostic Tools Used by Doctors

February 8, 2023
get a first report on injury after an incident
DiagnosticsNews

What’s a First Report of Injury or Illness Form?

September 12, 2022
The Top Benefits of a Wearable Blood Pressure Monitor Watch
DiagnosticsHealth

The Top Benefits of a Wearable Blood Pressure Monitor Watch

June 13, 2022
DiagnosticsRemote Diagnostics

6 Innovative Technologies Making Medical Diagnostics More Predictive

February 16, 2022
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?